NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
4.680
-0.180 (-3.70%)
At close: Jan 26, 2026, 4:00 PM EST
4.680
0.00 (0.00%)
After-hours: Jan 26, 2026, 6:30 PM EST
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $49.86 million as of January 26, 2026. Its market cap has increased by 175.77% in one year.
Market Cap
49.86M
Enterprise Value
46.93M
1-Year Change
175.77%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $49.86M, an increase of 171.37%. That is a compound annual growth rate of 50.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 51.77M | 7.05% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 55.90M |
| PDS Biotechnology | 51.98M |
| OS Therapies | 51.77M |
| iBio, Inc. | 50.60M |
| Aligos Therapeutics | 49.97M |
| Impact BioMedical | 49.36M |
| CEL-SCI | 49.02M |
| ABVC BioPharma | 48.56M |